The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo

Enterovirus 71 (EV71) causes severe central nervous system infections, leading to cardiopulmonary complications and death in young children. There is an urgent unmet medical need for new pharmaceutical agents to control EV71 infections. Using a multidisciplinary approach, we found that the approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Peijun, Zou, Gang, Bailly, Benjamin, Xu, Shanshan, Zeng, Mei, Chen, Xinsheng, Shen, Liang, Zhang, Ying, Guillon, Patrice, Arenzana-Seisdedos, Fernando, Buchy, Philippe, Li, Jian, von Itzstein, Mark, Li, Qihan, Altmeyer, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185360/
https://www.ncbi.nlm.nih.gov/pubmed/26038755
http://dx.doi.org/10.1038/emi.2014.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185360/
https://www.ncbi.nlm.nih.gov/pubmed/26038755
http://dx.doi.org/10.1038/emi.2014.60

Ejemplares similares